[VIRTUAL] Biosimilar TAB008 compared with bevacizumab in advanced non:squamous, non-small cell, EGFR wildtype lung cancer patients

paclitaxel - Generic mfg.

carboplatin - Generic mfg.

theralizumab (TAB08) - TheraMab

Pusintin (bevacizumab biosimilar) - TOT Biopharm

https://oncologypro.esmo.org/meeting-resources/esmo-asia-virtual-congress-2020/biosimilar-tab008-compared-with-bevacizumab-in-advanced-non-squamous-non-small-cell-egfr-wildtype-lung-cancer-patients

Z. Zhou1; S. Lu1; S. Qin2; J. Chen3; K. Gu4; P. Sun5; Y. Pan6; G. Yu7; K. Ma8; J. Shi9; Y. Sun10; L. Yang2; P. Chen11; A. Liu12; J. He13; X. Li14; L. Wang14

Oct 8, 2020